283 related articles for article (PubMed ID: 17198225)
41. Magnetic resonance imaging measurements of vascular permeability and extracellular volume fraction of breast tumors by dynamic Gd-DTPA-enhanced relaxometry.
Vincensini D; Dedieu V; Eliat PA; Vincent C; Bailly C; de Certaines J; Joffre F
Magn Reson Imaging; 2007 Apr; 25(3):293-302. PubMed ID: 17371717
[TBL] [Abstract][Full Text] [Related]
42. Dynamic magnetic resonance perfusion imaging of brain tumors.
Covarrubias DJ; Rosen BR; Lev MH
Oncologist; 2004; 9(5):528-37. PubMed ID: 15477637
[TBL] [Abstract][Full Text] [Related]
43. Brain tumor enhancement in magnetic resonance imaging: dependency on the level of protein binding of applied contrast agents.
Wintersperger BJ; Runge VM; Tweedle MF; Jackson CB; Reiser MF
Invest Radiol; 2009 Feb; 44(2):89-94. PubMed ID: 19077910
[TBL] [Abstract][Full Text] [Related]
44. Detection of cerebral metastases on magnetic resonance imaging: intraindividual comparison of gadobutrol with gadopentetate dimeglumine.
Anzalone N; Gerevini S; Scotti R; Vezzulli P; Picozzi P
Acta Radiol; 2009 Oct; 50(8):933-40. PubMed ID: 19626475
[TBL] [Abstract][Full Text] [Related]
45. Dynamic contrast enhanced MRI in prostate cancer.
Alonzi R; Padhani AR; Allen C
Eur J Radiol; 2007 Sep; 63(3):335-50. PubMed ID: 17689907
[TBL] [Abstract][Full Text] [Related]
46. Dynamic contrast-enhanced breast MR imaging.
Moon M; Cornfeld D; Weinreb J
Magn Reson Imaging Clin N Am; 2009 May; 17(2):351-62. PubMed ID: 19406363
[TBL] [Abstract][Full Text] [Related]
47. Perfusion magnetic resonance imaging in psychiatry.
Théberge J
Top Magn Reson Imaging; 2008 Apr; 19(2):111-30. PubMed ID: 19363433
[TBL] [Abstract][Full Text] [Related]
48. Perfusion measurement using DCE-MRI: implications for hyperthermia.
Lüdemann L; Wust P; Gellermann J
Int J Hyperthermia; 2008 Feb; 24(1):91-6. PubMed ID: 18214772
[TBL] [Abstract][Full Text] [Related]
49. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma.
Pauliah M; Saxena V; Haris M; Husain N; Rathore RK; Gupta RK
Magn Reson Imaging; 2007 Nov; 25(9):1292-9. PubMed ID: 17490844
[TBL] [Abstract][Full Text] [Related]
50. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
51. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial.
Kim RJ; Albert TS; Wible JH; Elliott MD; Allen JC; Lee JC; Parker M; Napoli A; Judd RM;
Circulation; 2008 Feb; 117(5):629-37. PubMed ID: 18212288
[TBL] [Abstract][Full Text] [Related]
52. [Magnetic tomography--new imaging techniques and future perspectives].
Gjesdal KI; Smith HJ
Tidsskr Nor Laegeforen; 2000 May; 120(13):1562-6. PubMed ID: 10916480
[TBL] [Abstract][Full Text] [Related]
53. Gadolinium(III)-based blood-pool contrast agents for magnetic resonance imaging: status and clinical potential.
Mohs AM; Lu ZR
Expert Opin Drug Deliv; 2007 Mar; 4(2):149-64. PubMed ID: 17335412
[TBL] [Abstract][Full Text] [Related]
54. Extracellular gadolinium-based contrast media: differences in diagnostic efficacy.
van der Molen AJ; Bellin MF
Eur J Radiol; 2008 May; 66(2):168-74. PubMed ID: 18372137
[TBL] [Abstract][Full Text] [Related]
55. [Utility of MRI contrast agents for diagnosis and treatment follow-up in cancer].
Siauve N; Clément O
Bull Cancer; 2007 Feb; 94(2):139-46. PubMed ID: 17337383
[TBL] [Abstract][Full Text] [Related]
56. Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging: a quantitative MRI study.
Bendszus M; Ladewig G; Jestaedt L; Misselwitz B; Solymosi L; Toyka K; Stoll G
Brain; 2008 Sep; 131(Pt 9):2341-52. PubMed ID: 18669504
[TBL] [Abstract][Full Text] [Related]
57. Whole-body MRI for the staging and follow-up of patients with metastasis.
Schmidt GP; Reiser MF; Baur-Melnyk A
Eur J Radiol; 2009 Jun; 70(3):393-400. PubMed ID: 19457631
[TBL] [Abstract][Full Text] [Related]
58. Blood-brain barrier imaging and therapeutic potentials.
Rebeles F; Fink J; Anzai Y; Maravilla KR
Top Magn Reson Imaging; 2006 Apr; 17(2):107-16. PubMed ID: 17198226
[TBL] [Abstract][Full Text] [Related]
59. In vivo visualization of focal demyelination in peripheral nerves by gadofluorine M-enhanced magnetic resonance imaging.
Wessig C; Bendszus M; Stoll G
Exp Neurol; 2007 Mar; 204(1):14-9. PubMed ID: 17112515
[TBL] [Abstract][Full Text] [Related]
60. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
